All posts by: Michael Zand

About Michael Zand

The Biological Clock Regulating Skin Stem Cell Metabolism – Science 2.0

Continue reading

2015-01-08 NEWS

The Biological Clock Regulating Skin Stem Cell Metabolism
Science 2.0
A study of circadian rhythms in skin stem cells finds that this biological clock plays a key role in coordinating daily metabolic cycles and cell division. The paper shows how the body’s intrinsic day-night cycles protect and nurture stem cell
Circadian Rhythms Regulate Skin Stem Cell Metabolism, ExpansionSleep Review

all 2 news articles »

Continue reading

2015-01-08 NEWS

Healthline

Most MS Patients Who Received Stem Cell Transplants Still in Remission 3
Healthline
Three years after the stem cell study HALT-MS began, many of the multiple sclerosis (MS) patients who took part are still in remission. The phase 2 study has demonstrated impressive results by rebuilding the immune system using a patient’s own stem cells.

Continue reading

2015-01-08 NEWS

Healthline

Most MS Patients Who Received Stem Cell Transplants Still in Remission 3
Healthline
Most of the multiple sclerosis (MS) patients who took part in the cutting-edge stem cell study HALT-MS are still in remission years later. The phase 2 study has demonstrated impressive results by rebuilding the immune system using a patient’s own stem

Continue reading

2015-01-07 NEWS

Regulatory Focus

EU’s First Stem Cell Treatment Recommended by EMA
Regulatory Focus
A major milestone in stem cell therapy was reached in December 2014 when a European Medicines Agency (EMA) committee recommended the conditional approval of Holoclar, the first stemcell product to be recommended for approval in the EU.

Continue reading

2015-01-07 NEWS

Regulatory Focus

EU’s First Stem Cell Treatment Recommended by EMA
Regulatory Focus
A major milestone in stem cell therapy was reached in December 2014 when a European Medicines Agency (EMA) committee recommended the conditional approval of Holoclar, the first stemcell product to be recommended for approval in the EU.

Continue reading

2015-01-07 NEWS

StemBioSys CEO to present at San Francisco biotech conference
San Antonio Business Journal
StemBioSys’ Hutchens will have an opportunity to present the San Antonio-based biomedical company’s work in advanced stem cell technologies to investors and pharmaceutical executives. StemBioSys, a privately held company, is gaining traction in the …

Continue reading

2015-01-07 NEWS

Bioscience Technology

Mystery Lingers Over STAP “Acid Bath” Stem Cells
Bioscience Technology
Embryo made from stressed stem cells. (Source: RIKEN)An investigatory panel hired by the Riken Institute in Toyko, Japan recently issued reports finding that STAP “acid bath” stem cells were, in the main, simply garden-variety embryonic stem (ES) cell